Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter
This is a prospective equivalence colonoscopy study evaluating whether overall adenoma detection rate (ADR) is a reliable alternate for screening ADR. Overall indication includes screening, surveillance, and diagnostic indications.
| Condition(s) | Adenoma Detection Rate, Colonoscopy |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | This is a prospective equivalence colonoscopy study evaluating whether overall adenoma detection rate (ADR) is a reliable alternate for screening ADR. Overall indication includes screening, surveillance, and diagnostic indications. |
| Who can participate | Inclusion Criteria: * consecutive patients aged ≥50 years undergoing colonoscopy are eligible for enrollment. Exclusion Criteria: * high risk family history of colorectal cancer (CRC) e.g., familial adenomatous polyposis, hereditary non-polyposis CRC syndrome, multiple first degree relatives with CRC, or a single first degree relative with CRC at \<60 years * serrated polyposis syndrome * inflammatory bowel disease * colonoscopy to remove a large neoplastic polyps * obstructive lesions of the colon * gastrointestinal bleeding * current participation in other studies * hospitalized patients * mental retardation * pregnancy * refusal to provide a written informed consent. |
| Ages | 50 Years to 80 Years |
| Sex | All |
| Lead sponsor | Evergreen General Hospital, Taiwan |
| Locations | North Hills, California, United States; Kaohsiung City, Taiwan; Kaohsiung City, Taiwan; Keelung, Taiwan; Taoyuan, Taiwan; Taoyuan, Taiwan |
| Start date | 2021-11-20 |
| NCT ID | NCT05125939 |
| Official listing | https://clinicaltrials.gov/study/NCT05125939 |